Phillips-Medisize A/S — Credit Rating and Financial Key Figures

Phillips-Medisize A/S (CVR number: 24053415) is a company from STRUER. The company reported a net sales of 360.6 mDKK in 2021, demonstrating a growth of 31.1 % compared to the previous year. The operating profit percentage was at 13.9 % (EBIT: 50.2 mDKK), while net earnings were 36.9 mDKK. The profitability of the company measured by Return on Assets (ROA) was 21.2 %, which can be considered excellent and Return on Equity (ROE) was 20.5 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 54.1 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. Phillips-Medisize A/S's liquidity measured by quick ratio was 2 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.